The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WRAPUP 3-'The beginning of the end': Europe rolls out vaccines to fight pandemic

Sun, 27th Dec 2020 10:17

(Adds quotes from Macron, Greece, Norway, detail and background
on new variants, German glitches)

* Goal is to offer vaccine to all adults through 2021

* EU has secured contracts for 2 billion-plus doses

* Frontline workers and elderly among those prioritised

* 'Thank God,' says first recipient in Spain, 96

By Isla Binnie and Giselda Vagnoni

MADRID/ROME, Dec 27 (Reuters) - Europe launched a mass
COVID-19 vaccination drive on Sunday with pensioners and medics
lining up to get the first shots to see off a pandemic that has
crippled economies and claimed more than 1.7 million lives
worldwide.

"Thank God," 96-year-old Araceli Hidalgo said as she became
the first person in Spain to have a vaccine at her care home in
Guadalajara near the capital Madrid. "Let's see if we can make
this virus go away."

In Italy, the first country in Europe to record significant
numbers of infections, 29-year-old nurse Claudia Alivernini was
one of three medical staff at the head of the queue for the shot
developed by Pfizer and BioNTech.

"It is the beginning of the end ... it was an exciting,
historic moment," she said at Rome's Spallanzani hospital.

The region of 450 million people is trying to catch up with
the United States and Britain which have both already started
vaccinations using the Pfizer/BioNTech shot.

The EU is due to receive 12.5 million doses of the shot by
the end of the year, enough to vaccinate 6.25 million people
based on the two-dose regimen. The companies are scrambling to
meet global demand and aim to make 1.3 billion shots next year.

Europe has secured contracts with a range of drugmakers
besides Pfizer including Moderna and AstraZeneca
, for a total of more than two billion vaccine doses and
has set a goal for all adults to be inoculated during 2021.

While Europe has some of the best-resourced healthcare
systems in the world, the sheer scale of the effort means some
countries are calling on retired medics to help while others
have loosened rules for who is allowed to give the injections.

With surveys pointing to high levels of hesitancy towards
the vaccine in countries from France to Poland, leaders of the
27-country European Union are promoting it as the best chance of
getting back to something like normal life next year.

"We have a new weapon against the virus: the vaccine. We
must stand firm, once more," tweeted French President Emmanuel
Macron, who tested positive for the coronavirus this month and
left quarantine on Christmas Eve.

SOLAR-POWERED PAVILIONS

After European governments were criticised for failing to
work together to counter the spread of the virus in early 2020,
the goal this time is to ensure that there is equal access to
the vaccines across the region.

But even then, Hungary on Saturday jumped the gun on the
official roll-out by administering shots to frontline workers at
hospitals in the capital Budapest.

Slovakia also went ahead with some inoculations of
healthcare staff on Saturday and in Germany, a small number of
people at a care home were inoculated a day early too.

"We don't want to waste that one day that the vaccine loses
shelf life," Karsten Fischer, from the pandemic staff of the
Harz district in the German state of Saxony-Anhalt, told local
broadcaster MDR.

The distribution of the shot presents tough challenges as
the vaccine uses new mRNA technology and must be stored at
ultra-low temperatures of about -70 degrees Celsius (-112°F).

In Germany, several vaccination centres in Northern Bavaria
held off from inoculating people after uncertainty arose on
whether the cold chain had been maintained.
"When reading the temperature loggers that were enclosed in
the cool boxes, doubts arose about the compliance with the cold
chain requirements", the vaccination centres of Coburg,
Lichtenfels, Kronach, Kulmbach, Hof, Bayreuth and Wunsiedel said
in a joint statement.
The Pfizer shots being used in Europe were shipped from its
factory in Puurs, Belgium, in specially designed containers
filled with dry ice. They can be stored for up to six months at
Antarctic winter temperatures, or for five days at 2C to 8C, a
type of refrigeration commonly available at hospitals.

Beyond hospitals and care homes, sports halls and convention
centres left vacant by lockdown restrictions will become venues
for mass inoculations.

In Italy, temporary solar-powered healthcare pavilions
designed to look like five-petalled primrose flowers - a symbol
of spring - sprouted in town squares.

NEW VARIANT

At the Santa Maria hospital in Portugal's capital Lisbon,
Pedro Pires waited for a shot with other nurses at the end of a
10-hour overnight shift. "It has been tiring ... a lot of work,"
he told Reuters.

Branka Anicic, 81, a resident of a care home in Zagreb and
became the first person to get a shot in Croatia. "I'm happy I
will now be able to see my great-grandchildren," she said.

Vaccinations also started in Norway, which is not a member
of the bloc but part of the EU's drive.

"I feel like a historical figure ... almost like the first
man on the Moon," said care home resident Svein Andersen, 67, as
he received the country's first shot in the capital Oslo.

Some other European countries outside the EU, such as
Britain, Switzerland and Serbia, have already started
vaccinating their citizens with the Pfizer jab in recent weeks.

The vaccination drive is all the more urgent because of the
concern around new variants of the virus linked to a rapid
expansion of cases in Britain and South Africa.

"We know that the pandemic won't just disappear as of today,
but the vaccine is the beginning of the victory over the
pandemic, the vaccine is a 'game changer'. We have always know
that, and today is the first day of this new phase," Austrian
Chancellor Sebastian Kurz.

Over the past week, cases of the UK variant have been
detected in Australia, Hong Kong and in several European
countries, mostly recently Sweden and France. So far, scientists
say there is no evidence to suggest the vaccines developed will
be any less effective against them.

In Spain, doses were delivered by air to its island
territories and the North African enclaves of Ceuta and Melilla.

"Today is the first day of the countdown to getting our
lives back," said Vassilis Kikilias, the health minister of
Greece where the roll-out was a more ceremonial affair. The
president, the premier, the military chief and a bishop were all
due to get shots on Sunday.

"We are at war, but our weapon has arrived and it is in
these small vials," the head of Bulgaria's anti-virus taskforce,
General Ventsislav Mutafchiiski said after getting his
vaccination in Sofia.

(Additional reporting by Catarina Demony in Lisbon, Silke
Koltrowitz in Vienna, Robert Muller in Prague, Tsvetelia Tsolova
in Sofia, Igor Ilic in Zagreb, Nerijus Adomaitis in oslo,
Michele Kambas in Athens and Benoit Van Overstraeten in Paris;
Writing by Mark John and Andrew Heavens; Editing by David
Clarke)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.